US 11807658
CD73 inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 11807658 (CD73 inhibitors) held by ORIC PHARMACEUTICALS, INC. expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ORIC PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K45/06, A61P, A61P25/28